viewEXMceuticals Inc

EXMceuticals aiming to be 'largest volume and lowest cost' producer of CBD products

Jonathan Summers, chairman of EXMceuticals Inc (CSE:EXM), introduces the business to Proactive London's Andrew Scott.

''The plan for the business, which we've already embarked on and are executing, is to grow large volumes of cannabis in Africa on an industrial scale, process that locally, refine it in Portugal and access all the end markets in North America and Europe.

''If you just look at Europe and ignore the rest of the world you have 750 million people who are increasingly interested and getting very excited about CBD as a health supplement and I think the potential for this industry and companies in this space, if they execute, could be very substantial''.

Quick facts: EXMceuticals Inc


Price: 0.2 CAD

Market Cap: $15.15 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


EXMceuticals now '100% focused on being a refining bioscience business in...

EXMceuticals Inc's (CSE:EXM) Jonathan Summers speaks to Proactive London's Katie Pilbeam about their cannabis research and development. Summers explains that the company has recently transitioned from being active in Africa to focusing their attentions solely onto Portugal. The company...

on 14/9/20

2 min read